Page last updated: 2024-08-23

amikacin and Ciliary Dyskinesia, Primary, 1

amikacin has been researched along with Ciliary Dyskinesia, Primary, 1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhattacharyya, D; Brewer, CC; Fleshner, M; Folio, LR; Glaser, TS; Holland, SM; Olivier, KN; Park, IK; Prevots, DR; Sampaio, EP; Shallom, S; Shaw, PA; Siegelman, JR; Zalewski, CK; Zelazny, AM	1

Other Studies

1 other study(ies) available for amikacin and Ciliary Dyskinesia, Primary, 1

Article	Year
Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease. Annals of the American Thoracic Society, 2014, Volume: 11, Issue:1 Topics: Administration, Inhalation; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bronchiectasis; Cystic Fibrosis; Female; Humans; Kartagener Syndrome; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Pulmonary	2014

Article

Year

Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease.

Annals of the American Thoracic Society, 2014, Volume: 11, Issue:1

Topics: Administration, Inhalation; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bronchiectasis; Cystic Fibrosis; Female; Humans; Kartagener Syndrome; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Pulmonary

2014